13F Filings History of Merck & Co., Inc.

Latest 13F report
Q3 2025 - 12 Nov 2025
Value $
$228,030,003
Signature - Title
Kelly Grez - Corporate Secretary
Location
Rahway, NJ
Summary
This page shows a list of all the recent 13F filings made by Merck & Co., Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Merck & Co., Inc. reported 13 stock holdings with total value $228,030,003 as of Q3 2025. Top holdings included PSNL, MRNA, KYMR, ALEC, and EVAX.

Notify me when Merck & Co., Inc. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 13 $228,030,003 $0 $0 $0 PSNL, MRNA, KYMR, ALEC, EVAX 13F-HR 12 Nov 2025, 16:11
Q2 2025 13 $215,600,331 +$31,109 $0 +$31,109 PSNL, MRNA, KYMR, ALEC, EVAX 13F-HR 13 Aug 2025, 17:05
Q1 2025 12 $164,284,061 +$1,242,917 -$2,615,187 -$1,372,270 MRNA, PSNL, KYMR, ALEC, EVAX 13F-HR 14 May 2025, 16:02
Q4 2024 13 $258,037,542 $0 $0 $0 MRNA, PSNL, KYMR, ALEC, STRO 13F-HR 14 Feb 2025, 11:14